NAD Recommends P&G Discontinue ‘100% Odor Protection’ Claim for Secret ‘Clinical Strength,’ Finds Certain Claims Supported

New York, NY – Oct. 30,  2014 – The National Advertising Division has recommended that The Procter & Gamble Company discontinue certain claims for the company’s “Secret Clinical Strength” antiperspirant/deodorant products, including claims of “100% odor protection.”

NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.

Claims, including those made in television, print, and social media advertising, as well as on the company website, were challenged by Unilever United States, Inc., the maker of competing antiperspirants/deodorants.

NAD examined express claims for “Secret Clinical Strength Clear Gel” and “Secret Clinical Strength Invisible Solid” that included:

  • “100% odor protection” for products labeled with a “48 hour odor protection” claim.
  • “100% odor protection* *as typically noticed by others.”
  • “#100% or Nothing”

NAD considered also whether the advertising implied that:

  • Secret Clinical Strength products are clinically proven to provide complete protection from underarm odor for 48 hours for 100% of women in 100% of circumstances, including after enduring stress, physical activity, and heat.

The challenged claim “100% odor protection*” appeared with the disclosure  “*as typically noticed by others,” and was featured in a television commercial and in print, web, and social media advertising.

The broadcast advertising depicted a young executive preparing for an important meeting and the voiceover stated: “The day of my first presentation I was 80% nervous to lead the meeting, 90% confident I’d say the right things, but with 100% odor protection, I knew I had nothing to worry about.”

In conjunction with the voiceover, the text “80% nervous,” “90% confident,” and “100% odor protection” appeared in large print over the center of the screen. The disclaimer “*as typically noticed by others,” appeared in significantly smaller type at the bottom.

The voiceover continued: “The new Secret Clinical Strength Collection has the unique, high-efficiency technology that helps eliminate odor for 100% odor protection,” and the “100% odor protection” claim appeared on screen again with the disclaimer. Finally, the voiceover stated: “I never settle for less than 100% so I can be 100% fearless.”

The challenger argued that the claim was a strong quantified performance claim that should be read in conjunction with the “48 hour protection” claim on the packaging. It contended that the advertiser’s claim conveyed the message that no person using the product would emit any underarm malodor for two full days. The advertiser argued that the “100% odor protection” claim as presented was used colloquially, in the context of a play on percentages in its television commercial and advertising campaign. Neither party provided consumer perception evidence to support its position regarding how consumers were likely to interpret the challenged claims.

NAD determined that the claim conveyed a message of “objective certainty,” and that consumers could quite reasonably understand the claim to mean that they would not emit any underarm odor when using Secret Clinical Strength.

Regarding the advertiser’s disclosure, NAD noted that even if consumers noticed, read, and understood the phrase, “as typically noticed by others,” they would not necessarily understand that the promised 100% odor protection would only be provided in some, and not “100%,” of situations.

Following its review of the advertiser’s evidence, NAD noted that the advertiser’s testing demonstrated the high level of overall effectiveness of Secret Clinical Strength, but determined that its test results were not sufficient to provide a reasonable basis for P&G’s quantified and absolute “100% odor protection” claim. NAD recommended that the claim be discontinued.

NAD noted its appreciation for P&G’s permanent discontinuance of certain versions of the challenged claims, some of which it noted were made in error.

NAD found that the advertiser provided a reasonable basis for its claim, “Unlike smooth solid clinical strength antiperspirants which can leave white marks behind, Secret Clinical Strength Clear Gel goes on clear with no white marks,” but that its broader “Clear Gel – For a Clean No White Marks Look” claim was not adequately supported. NAD recommended that this version of the claim be discontinued.

Finally, NAD determined that a “Doctor Recommended” claim challenged by Unilever was not substantiated and recommended that the claim be discontinued or modified to reflect that the product is “Doctor Endorsed.”

P&G, in its advertiser’s statement, said that although the company “does not agree with all of NAD’s conclusions, it is pleased that NAD generally recognizes the product’s superior efficacy, and P&G will take NAD’s recommendations into account in future advertising.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Refers “Made in USA” Claims by Larose Industries d/b/a Roseart and Cra-Z-Art to the Federal Trade Commission

New York, NY – January 10, 2025 – The National Advertising Division referred advertising claims by Larose Industries, operating under the names Roseart and Cra-Z-Art, that its products are “Made in USA” to the Federal Trade Commission (FTC) after Larose Industries failed to respond to the inquiry.

Read the Decision Summary
Decision

National Advertising Division Recommends T-Mobile Discontinue or Modify 20% Savings vs. ‘The Other Big Guys’ Claim; T-Mobile to Appeal

New York, NY – January 9, 2025 – The National Advertising Division recommended that T-Mobile discontinue or modify its advertising to avoid conveying the comparative claim that consumers can “save 20% every month vs. the other big guys” if they subscribe to T-Mobile in markets where Spectrum Mobile also...

Read the Decision Summary
Decision

In National Advertising Division Fast-Track SWIFT Challenge Behr Voluntarily Discontinues “No Comparable Product” Claim

New York, NY – January 8, 2025 – In a National Advertising Division Fast-Track SWIFT challenge brought by Benjamin Moore, Behr voluntarily discontinued its “No Comparable Product” claim.

Read the Decision Summary
Decision

National Advertising Division Finds Charter’s “Unlimited” Claims Supported; Recommends Clear & Conspicuous Speed Limitation Disclosures

New York, NY – January 7, 2025 – The National Advertising Division found that Charter substantiated certain express and implied claims about its Spectrum Mobile “Unlimited” and “Unlimited Plus” wireless data plans but recommended that Charter modify its website advertising to disclose high speed data...

Read the Decision Summary